Geranium oil, derived from the fragrant geranium plant (Pelargonium graveolens), is known for its versatile benefits in both skincare and overall health. This essential oil, known for its soothing ...

About Xlear, Inc. Xlear, Inc. specializes in xylitol-based products for oral and nasal hygiene. The company is dedicated to improving health outcomes through innovative, natural solutions.

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...

For instance, he referenced a 2024 clinical trial demonstrating that nasal hygiene reduced ... gum, mouth spray, among others. Xlear has supported extensive research on the advantages of xylitol ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

Post-nasal drip occurs when excess mucus accumulates in the back of the throat or nose, primarily due to allergies, infections, or irritants. Symptoms include throat clearing and coughing.

OKAY, HONEY, COME SIT HERE. TODAY, JOE IS TESTING SOMETHING NEW. A MEDICATION CALLED FOR INSIDE THIS NASAL SPRAY. ONE, TWO. THREE. JOE IS THE FIRST PATIENT WITH ALZHEIMER’S TO TRY THIS DRUG.

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.